Adverum Biotechnologies Statistics
Total Valuation
ADVM has a market cap or net worth of $61.38 million. The enterprise value is $108.89 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ADVM has 20.98 million shares outstanding. The number of shares has increased by 45.11% in one year.
| Current Share Class | 20.98M |
| Shares Outstanding | 20.98M |
| Shares Change (YoY) | +45.11% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 11.96% |
| Owned by Institutions (%) | 38.04% |
| Float | 11.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 58.14 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 108.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.54
| Current Ratio | 1.54 |
| Quick Ratio | 1.42 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -229.34% and return on invested capital (ROIC) is -69.74%.
| Return on Equity (ROE) | -229.34% |
| Return on Assets (ROA) | -62.55% |
| Return on Invested Capital (ROIC) | -69.74% |
| Return on Capital Employed (ROCE) | -270.17% |
| Revenue Per Employee | $6,452 |
| Profits Per Employee | -$1.09M |
| Employee Count | 155 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.67% in the last 52 weeks. The beta is 0.77, so ADVM's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -57.67% |
| 50-Day Moving Average | 2.53 |
| 200-Day Moving Average | 3.96 |
| Relative Strength Index (RSI) | 61.56 |
| Average Volume (20 Days) | 94,924 |
Short Selling Information
The latest short interest is 986,337, so 4.70% of the outstanding shares have been sold short.
| Short Interest | 986,337 |
| Short Previous Month | 1.03M |
| Short % of Shares Out | 4.70% |
| Short % of Float | 8.68% |
| Short Ratio (days to cover) | 7.34 |
Income Statement
In the last 12 months, ADVM had revenue of $1.00 million and -$169.49 million in losses. Loss per share was -$8.10.
| Revenue | 1.00M |
| Gross Profit | -109.41M |
| Operating Income | -175.13M |
| Pretax Income | -113.99M |
| Net Income | -169.49M |
| EBITDA | -172.21M |
| EBIT | -175.13M |
| Loss Per Share | -$8.10 |
Full Income StatementBalance Sheet
The company has $44.40 million in cash and $92.22 million in debt, giving a net cash position of -$47.82 million or -$2.28 per share.
| Cash & Cash Equivalents | 44.40M |
| Total Debt | 92.22M |
| Net Cash | -47.82M |
| Net Cash Per Share | -$2.28 |
| Equity (Book Value) | -20.22M |
| Book Value Per Share | -0.96 |
| Working Capital | 17.04M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$130.91 million and capital expenditures -$622,000, giving a free cash flow of -$131.53 million.
| Operating Cash Flow | -130.91M |
| Capital Expenditures | -622,000 |
| Free Cash Flow | -131.53M |
| FCF Per Share | -$6.27 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -17,513.20% |
| Pretax Margin | -16,949.20% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADVM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -45.11% |
| Shareholder Yield | -45.11% |
| Earnings Yield | -277.56% |
| FCF Yield | -215.40% |
Analyst Forecast
The average price target for ADVM is $19.75, which is 575.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.75 |
| Price Target Difference | 575.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 135.43% |
| EPS Growth Forecast (5Y) | -23.83% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 21, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Mar 21, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ADVM has an Altman Z-Score of -22.14 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -22.14 |
| Piotroski F-Score | 1 |
